Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Green

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Emerging Microbes & Infections|October 16, 2025
Developing accessible and affordable tests to support mpox immunosurveillance and vaccine studiesSian E Faustini, Scott Jones, Christopher A Green, et al.
Science Translational Medicine|March 20, 2020
Priorities for developing respiratory syncytial virus vaccines in different target populationsSimon B Drysdale, Rachael S Barr, Christine S Rollier, et al.
The Lancet. Microbe|March 3, 2021
The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 eraMohammed Nabil Quraishi, Sahida Shabir, Susan E Manzoor, et al.
Archives of Disease in Childhood|September 6, 2015
Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthmaChristopher A Green, David Yeates, Allie Goldacre, et al.
International Immunopharmacology|February 3, 2005
A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine modelGareth D Griffiths, Gary Telford, Doreen S W Hooi, et al.
Vaccine|October 16, 2018
Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infectionHannah E Gerretsen, Stefania Capone, Alessandra Vitelli, et al.
The Lancet. Gastroenterology & Hepatology|April 3, 2020
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forwardChristopher A Green, Mohammed N Quraishi, Sahida Shabir, et al.
F1000Research|August 9, 2021
Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissionsSusan E Manzoor, Shafquat Zaman, Celina Whalley, et al.
Msphere|January 26, 2022
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I TrialChristine S Rollier, Christina Dold, Leanne Marsay, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2025
Differential control of mycobacterial growth ex vivo by COVID-19 patients is associated with CD8+ CD28+ T cellsAlba Llibre, Henna Siddiqui, Julie G Burel, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Emerging Microbes & Infections|October 16, 2025
Developing accessible and affordable tests to support mpox immunosurveillance and vaccine studiesSian E Faustini, Scott Jones, Christopher A Green, et al.
Science Translational Medicine|March 20, 2020
Priorities for developing respiratory syncytial virus vaccines in different target populationsSimon B Drysdale, Rachael S Barr, Christine S Rollier, et al.
The Lancet. Microbe|March 3, 2021
The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 eraMohammed Nabil Quraishi, Sahida Shabir, Susan E Manzoor, et al.
Archives of Disease in Childhood|September 6, 2015
Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthmaChristopher A Green, David Yeates, Allie Goldacre, et al.
International Immunopharmacology|February 3, 2005
A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine modelGareth D Griffiths, Gary Telford, Doreen S W Hooi, et al.
Vaccine|October 16, 2018
Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infectionHannah E Gerretsen, Stefania Capone, Alessandra Vitelli, et al.
The Lancet. Gastroenterology & Hepatology|April 3, 2020
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forwardChristopher A Green, Mohammed N Quraishi, Sahida Shabir, et al.
F1000Research|August 9, 2021
Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissionsSusan E Manzoor, Shafquat Zaman, Celina Whalley, et al.
Msphere|January 26, 2022
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I TrialChristine S Rollier, Christina Dold, Leanne Marsay, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2025
Differential control of mycobacterial growth ex vivo by COVID-19 patients is associated with CD8+ CD28+ T cellsAlba Llibre, Henna Siddiqui, Julie G Burel, et al.
Pageof 5